R1 RCM's Robust Client Base And $1.2 Trillion Potential: The Growth Forecast By Analyst
Portfolio Pulse from Nabaparna Bhattacharya
Cantor Fitzgerald Research analyst Sarah James initiated coverage on R1 RCM Inc. with an Overweight rating and a price target of $20. The analyst is upbeat about R1's client base and sees potential for growth through cross-selling Cloudmed and R1. The company's target market of externally sourced RCM is expected to outpace the overall market growth. For FY23 and FY24, the analyst projects revenues of $2.266 billion and $2.712 billion respectively.
August 15, 2023 | 7:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
R1 RCM Inc. received an Overweight rating from Cantor Fitzgerald Research with a price target of $20. The company's growth potential is seen in its robust client base and cross-selling opportunities with Cloudmed.
The news is directly about R1 RCM Inc. and is positive. The Overweight rating from a reputable research firm indicates a bullish outlook for the company. The analyst's forecast of revenue growth and the potential of cross-selling with Cloudmed further supports this positive outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100